Service Provider Quality Benchmarking Reports
Showing 1–12 of 80 results
ISR has an unmatched level of expertise in the drug development and outsourcing space. This expertise is best reflected in our contract research organization (CRO) and service provider benchmarking reports. Sponsor organizations can access a unique resource to evaluate and select CROs and other service providers to ensure the best selection based on an organization’s needs. CROs and other service providers are provided an opportunity to evaluate their own services, measured against their competitors, to improve operational excellence, improve service quality to their customers, and win more business.
Whether you’re looking for information on how other small and emerging sponsors outsource their clinical development programs, how to select and use a bioanalytical lab, the best choice for your late-phase study research partner, or how preferred provider agreements affect small molecule drug product manufacturing, ISR has got you covered.
Contact sales@isrreports.com or call us at +1 (919) 301-0106 for information on report bundling options.
-
Biologic API CDMO Benchmarking for New & Emerging Biopharma
$3,950.00 – $7,900.00 -
Phase II/III CRO Benchmarking (14th Ed.)
$5,900.00 – $11,800.00 -
Phase I CRO Benchmarking (14th Ed.)
$5,900.00 – $11,800.00 -
Small Molecule Drug Product CDMO Benchmarking (5th Ed.)
$5,900.00 – $11,800.00 -
Small Molecule API CDMO Benchmarking (7th Ed.)
$5,900.00 – $11,800.00 -
Biologic API CDMO Benchmarking (7th Ed.)
$5,900.00 – $11,800.00 -
Biologic Drug Product CDMO Benchmarking (5th Ed.)
$5,900.00 – $11,800.00 -
Phase II/III CRO Benchmarking—Small Pharma Market (2nd Ed.)
$3,450.00 – $6,900.00 -
Phase I CRO Benchmarking (13th Ed.)
$5,400.00 – $10,800.00 -
Phase II/III CRO Benchmarking (13th Ed.)
$5,400.00 – $10,800.00 -
eCOA/ePRO Benchmarking & Market Dynamics (4th Ed.)
$4,460.00 – $8,920.00 -
Biologic Drug Product CDMO Benchmarking (4th Ed.)
$5,400.00 – $10,800.00
